NeuralStem competitors

NeuralStem's competitors include InVivo Therapeutics, IO Biotech, Pandion Therapeutics and Rubius Therapeutics
Add company...
NeuralStem
NeuralStem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
InVivo Therapeutics
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
IO Biotech
IO Biotech is a clinical stage biotech company developing disruptive immune therapies.
Pandion Therapeutics
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
Founding Date
Founding Date
1996
Founding Date
2005
Founding Date
2014
Founding Date
2017
Founding Date
2013
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Rockville, US HQ
Locations
Cambridge, US HQ
Locations
København, DK HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Employees
Employees
11
Employees
37
Employees
N/A
Employees
13
Employees
831% increase
Valuation ($)
Valuation ($)
24.7 m
Valuation ($)
10.5 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
1.2 k
Facebook likes
12.4 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
2.2 k
Twitter followers
1.2 k
Twitter followers
N/A
Twitter followers
40
Twitter followers
247

Financial

Net income
Net income
($21.1m) (FY, 2016)
Net income
($26.7m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 12m (over 2 years ago)
Latest funding round
$ 58m (5 months ago)
Latest funding round
$ 100m (4 months ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 75.2m
Total funding raised
$ 12m
Total funding raised
$ 58m
Total funding raised
$ 245m
For sources of this data, please see the company profileDownload Excel

View company profiles

InVivo Therapeutics
HQ
Cambridge, US
Employees
37

InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.

View company
IO Biotech
HQ
København, DK

IO Biotech is a clinical stage biotech company developing disruptive immune therapies.

View company
Pandion Therapeutics
HQ
Cambridge, US
Employees
13

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.

View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
83↑ 1% increase

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.

View company